Results 221 to 230 of about 25,924 (270)
Some of the next articles are maybe not open access.

MUSCLE GROWTH IN NORMAL AND SPASTIC MICE

Developmental Medicine & Child Neurology, 1984
SUMMARYLongitudinal muscle growth was studied in normal and spastic mice. Muscle growth takes place at the musculotendinous junction—the ‘muscle growth‐plate’. In spastic mice muscle growth is reduced by 45 per cent, resulting in contractures.RESUMECroissance musculaire chez les souris normales et spastiquesLa croissance longitudinale du muscle a ...
Nigel Blackburn   +3 more
openaire   +3 more sources

A model of muscle spasticity in opensim

Gait & Posture, 2013
Introduction: Computer simulations of human movement are commonly used to study normal and abnormal gait, for instance of subjects with spasticity. However, they generally do not include explicit models of spasticity. Our goal, therefore, was to develop a computer model of spasticity and to test this model by dynamic simulation of instrumented ...
Jaap Harlaar   +6 more
openaire   +2 more sources

Spastic Facial Muscle Disorders

2012
Facial muscles are a group of striated muscles that, among other things, control facial expression and are innervated by the facial nerve (CNVII). In contrast, the nearby eyelid retractor muscle and masticator muscles are innervated by the oculomotor (CNIII) and mandibular branch of trigeminal nerve (CNV), respectively.
Andrew R. Harrison   +2 more
openaire   +2 more sources

Treatment of spasticity with muscle afferent block

Neurology, 1999
In 1924, Walshe1 first reported that intramuscular injection of diluted procaine reduced muscle rigidity in a patient with postencephalitic parkinsonism. Its mechanism of action was attributed to blockade of muscle afferents because the muscle motor response elicited by electric stimulation was unchanged.
N. Hirota   +4 more
openaire   +3 more sources

Effect of Muscle Biomechanics on the Quantification of Spasticity

Annals of Biomedical Engineering, 2001
The impact of muscle biomechanics on spasticity was assessed by comparison of the reflex responses of the elbow and metacarpophalangeal (MCP) flexor muscles in individuals with chronic spastic hemiplegia following stroke. Specifically, methods were developed to quantify reflex responses and to normalize these responses for comparison across different ...
Brian D. Schmit   +2 more
openaire   +2 more sources

Muscle Elastography in Multiple Sclerosis Spasticity

Neurodegenerative Disease Management, 2016
Ultrasound elastography is a novel imaging modality for evaluating the elasticity of biological tissues. The technique is widely used in oncology to detect and differentiate malignant lesions in soft tissues. Studies have explored use of ultrasound elastography to measure the mechanical properties of muscle in patients with multiple sclerosis ...
openaire   +3 more sources

An adapted double threshold protocol for spastic muscles

2016 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC), 2016
The onset of muscle contraction has been an important element in the understanding of human motor control system as well as in the development of medical devices. This task is problematic in the study of spasticity using surface Electromyography (sEMG).
Vieira, Pedro Miguel   +3 more
openaire   +4 more sources

Developing a quantitative measure of muscle spasticity

IEEE 30th Annual Northeast Bioengineering Conference, 2004. Proceedings of the, 2004
Quantitative measurement of spasticity is necessary and can contribute to clinical rehabilitation management, which aims to restore and/or improve function in the affected part of the body. The proposed study shows that by using computerized motional analysis systems, a more quantitative measurement of muscle spasticity can be obtained.
Darnell Simon, Richard A. Foulds
openaire   +2 more sources

Update on tizanidine for muscle spasticity and emerging indications

Expert Opinion on Pharmacotherapy, 2008
Tizanidine hydrochloride, an alpha(2)-adrenergic receptor agonist, is a widely used medication for the treatment of muscle spasticity. Clinical studies have supported its use in the management of spasticity caused by multiple sclerosis (MS), acquired brain injury or spinal cord injury. It has also been shown to be clinically effective in the management
Edward Garay   +2 more
openaire   +3 more sources

Botulinum toxin A for spasticity, muscle spasms, and rigidity

Neurology, 1995
We studied the effects of botulinum toxin A in 12 patients with spasticity and in eight patients with rigidity. The study design was a double-blind, placebo-controlled crossover trial with botulinum toxin A versus saline. Using the Ashworth Scale for spasticity and the Unified Parkinson's Disease Rating Scale for rigidity, we gave the patients a tone ...
Bahman Jabbari   +2 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy